Jon M. Foster - 13 May 2025 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
13 May 2025
Net transactions value
-$5,797,661
Form type
4
Filing time
15 May 2025, 17:54:39 UTC
Previous filing
18 Feb 2025
Next filing
02 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Foster Jon M EVP and COO ONE PARK PLAZA, NASHVILLE /s/ Natalie Harrison Cline, Attorney-in-Fact 15 May 2025 0001513235

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Sale $5,797,661 -15,698 -55% $369.32 12,646 13 May 2025 Direct F1
transaction HCA Common Stock Gift $0 -1,080 -8.5% $0.000000 11,566 13 May 2025 Direct
transaction HCA Common Stock Gift $0 +1,080 +1.6% $0.000000 67,595 13 May 2025 By JMF Trust (Spouse and Robert Nagel, Co-Trustees)
transaction HCA Common Stock Gift $0 -2,075 -12% $0.000000 15,925 13 May 2025 By Spouse
transaction HCA Common Stock Gift $0 +2,075 +3.8% $0.000000 56,383 13 May 2025 By LCF Trust (Reporting Person, Trustee)
transaction HCA Common Stock Other $5,847,580 -15,925 -100% $367.20 0 13 May 2025 By Spouse F2
transaction HCA Common Stock Other $5,847,580 +15,925 +28% $367.20 72,308 13 May 2025 By LCF Trust (Reporting Person, Trustee) F2
holding HCA Common Stock 19,985 13 May 2025 By JMF Family Trust (Spouse, Trustee) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $368.80 to $370.56, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Pursuant to a power of substitution, on May 13, 2025, the Reporting Person's spouse transferred 15,925 shares of common stock of the Issuer to a trust account in exchange for assets of equal value. The transfer was made at a price per share equal to $367.195 (the average of the high and low prices of shares of common stock of the Issuer on May 13, 2025). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.
F3 On each of November 18, 2024 and February 18, 2025, a Form 4 was filed for the Reporting Person, and, due to administrative error, the indirect beneficial ownership held by the Reporting Person in the JMF Family Trust, which had been included in prior reports, was omitted. The beneficial ownership has been correctly reflected herein.